Clinical Scorecard: Evaluation of Ultrasound-Guided Percutaneous Radiofrequency Ablation Versus Surgical Reoperation for Recurrence of Papillary Thyroid Carcinoma in Proximal Cervical Lymph Nodes: A Propensity Score-Matched Analysis

At a Glance

Key Highlights

• RFA showed a mean volume reduction ratio of 0.97 ± 0.04 at 24 months.
• 42.3% of metastatic lymph nodes in the RFA group completely disappeared.
• RFA had significantly lower overall complication rates compared to RO (P<0.001).
• RFA associated with shorter procedure time, hospital stay, and less intraoperative blood loss.
• Subgroup analysis indicated safety differences were most evident in Type II lesions.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of recurrent papillary thyroid carcinoma confirmed through imaging and biopsy.

Management

• Consider RFA as a minimally invasive option for patients unsuitable for or unwilling to undergo reoperation.

Monitoring & Follow-up

• Follow-up for local recurrence and complications post-treatment.

Risks

• Potential for nerve injury and complications associated with surgical reoperation.

Patient & Prescribing Data

Patients with recurrent papillary thyroid carcinoma in cervical perineural regions.

RFA provides a low-trauma treatment option with faster recovery.

Clinical Best Practices

• Careful selection of patients for RFA based on lesion visibility and safety of hydrodissection.
• Utilization of ultrasound guidance for precise needle placement during RFA.

Related Resources & Content

• Fujian Provincial Hospital Study